国内买的到万赛维吗？

(Valganciclovir hydrochloride) is an oral anti-cytomegalovirus infection drug developed by the Swiss company Roche. It was approved by the US FDA in May 2001. It is clinically used to treat acute retinitis caused by CMV infection in patients with acquired immunodeficiency syndrome. In May 2003, its indications were expanded to prevent and treat secondary CMV infection in organ transplant recipients. Clinical studies have shown that the therapeutic effect of its drug is very significant, and it can significantly delay the survival period of patients and improve their quality of life. Can patients buy this drug in China?

Patients can buy this drug in China. Launched in China in 2006, it is suitable for the treatment of patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis and the prevention of CMV infection in high-risk solid organ transplant patients. Currently, Vancevir (valganciclovir hydrochloride) is available in all major infectious disease hospitals and pharmacies in China. However, because it is an imported original drug, it is relatively expensive. The domestic Vancevir (valganciclovir hydrochloride) specification is 450mg-60 tablets/box, and the price is about US$2,250.

If patients feel that the domestic price of Valganciclovir (valganciclovir hydrochloride) is unaffordable, they can also choose Roche’s original drug Valganciclovir (valganciclovir hydrochloride) sold in India. The price is the lowest in the world, and it is also the most purchased drug by domestic and foreign patients. India’s Valganciclovir (valganciclovir hydrochloride tablets, valgansiklovir) 450mg*60 tablets/box, priced at about US$750. Due to floating exchange rates, the price is not fixed. Please consult Medical Travel for specific prices.

Valgansiklovir is administered orally and should be taken with food. Valgansiklovir is rapidly and massively converted into ganciclovir. The bioavailability of valgansiklovir as measured as ganciclovir is 10 times higher than that of ganciclovir capsules, so the dosage and usage instructions for valgansiklovir described below should be strictly followed. Induction therapy of CMV retinitis: For patients with active CMV retinitis, the recommended dose is 900 mg (two 450 mg tablets) twice daily for 21 days. Prolonged induction therapy may increase the risk of bone marrow toxicity.